Healthcare costs of inflammatory bowel disease have shifted from hospitalisation and surgery towards anti-TNF alpha therapy: results from the COIN study

M.E. van der Valk; M.J.J. Mangen; M. Leenders; G. Dijkstra; A.A. van Bodegraven; H.H. Fidder; D.J. de Jong; M. Pierik; C.J. van der Woude; M.J.L. Romberg-Camps; C.H.M. Clemens; J.M. Jansen; N. Mahmmod; P.C. van de Meeberg; A. Jong; C.Y. Ponsioen; C.J.M. Bolwerk; J.R. Vermeijden; P.D. Siersema; M.G.H. van Oijen; B. Oldenburg

doi:10.1136/gutjnl-2012-303376

Healthcare costs of inflammatory bowel disease have shifted from hospitalisation and surgery towards anti-TNF alpha therapy: results from the COIN study

M.E. van der Valk, M.J.J. Mangen, M. Leenders, G. Dijkstra, A.A. van Bodegraven, H.H. Fidder, D.J. de Jong, M. Pierik, C.J. van der Woude, M.J.L. Romberg-Camps, C.H.M. Clemens, J.M. Jansen, N. Mahmmod, P.C. van de Meeberg, A. Jong, C.Y. Ponsioen, C.J.M. Bolwerk, J.R. Vermeijden, P.D. Siersema, M.G.H. van OijenB. Oldenburg

Gastroenterology and hepatology

Research output: Contribution to journal › Article › Academic › peer-review

Original language	Undefined/Unknown
Pages (from-to)	72-79
Journal	Gut
Volume	63
Issue number	1
DOIs	https://doi.org/10.1136/gutjnl-2012-303376
Publication status	Published - 2014

Access to Document

10.1136/gutjnl-2012-303376

Cite this

van der Valk, M. E., Mangen, M. J. J., Leenders, M., Dijkstra, G., van Bodegraven, A. A., Fidder, H. H., de Jong, D. J., Pierik, M., van der Woude, C. J., Romberg-Camps, M. J. L., Clemens, C. H. M., Jansen, J. M., Mahmmod, N., van de Meeberg, P. C., Jong, A., Ponsioen, C. Y., Bolwerk, C. J. M., Vermeijden, J. R., Siersema, P. D., ... Oldenburg, B. (2014). Healthcare costs of inflammatory bowel disease have shifted from hospitalisation and surgery towards anti-TNF alpha therapy: results from the COIN study. Gut, 63(1), 72-79. https://doi.org/10.1136/gutjnl-2012-303376

@article{02b5130e15f042cbbedb5756774b2b44,

title = "Healthcare costs of inflammatory bowel disease have shifted from hospitalisation and surgery towards anti-TNF alpha therapy: results from the COIN study",

author = "{van der Valk}, M.E. and M.J.J. Mangen and M. Leenders and G. Dijkstra and {van Bodegraven}, A.A. and H.H. Fidder and {de Jong}, D.J. and M. Pierik and {van der Woude}, C.J. and M.J.L. Romberg-Camps and C.H.M. Clemens and J.M. Jansen and N. Mahmmod and {van de Meeberg}, P.C. and A. Jong and C.Y. Ponsioen and C.J.M. Bolwerk and J.R. Vermeijden and P.D. Siersema and {van Oijen}, M.G.H. and B. Oldenburg",

year = "2014",

doi = "10.1136/gutjnl-2012-303376",

language = "Undefined/Unknown",

volume = "63",

pages = "72--79",

journal = "Gut",

issn = "0017-5749",

publisher = "BMJ Publishing Group",

number = "1",

}

van der Valk, ME, Mangen, MJJ, Leenders, M, Dijkstra, G, van Bodegraven, AA, Fidder, HH, de Jong, DJ, Pierik, M, van der Woude, CJ, Romberg-Camps, MJL, Clemens, CHM, Jansen, JM, Mahmmod, N, van de Meeberg, PC, Jong, A, Ponsioen, CY, Bolwerk, CJM, Vermeijden, JR, Siersema, PD, van Oijen, MGH & Oldenburg, B 2014, 'Healthcare costs of inflammatory bowel disease have shifted from hospitalisation and surgery towards anti-TNF alpha therapy: results from the COIN study', Gut, vol. 63, no. 1, pp. 72-79. https://doi.org/10.1136/gutjnl-2012-303376

TY - JOUR

T1 - Healthcare costs of inflammatory bowel disease have shifted from hospitalisation and surgery towards anti-TNF alpha therapy: results from the COIN study

AU - van der Valk, M.E.

AU - Mangen, M.J.J.

AU - Leenders, M.

AU - Dijkstra, G.

AU - van Bodegraven, A.A.

AU - Fidder, H.H.

AU - de Jong, D.J.

AU - Pierik, M.

AU - van der Woude, C.J.

AU - Romberg-Camps, M.J.L.

AU - Clemens, C.H.M.

AU - Jansen, J.M.

AU - Mahmmod, N.

AU - van de Meeberg, P.C.

AU - Jong, A.

AU - Ponsioen, C.Y.

AU - Bolwerk, C.J.M.

AU - Vermeijden, J.R.

AU - Siersema, P.D.

AU - van Oijen, M.G.H.

AU - Oldenburg, B.

PY - 2014

Y1 - 2014

U2 - 10.1136/gutjnl-2012-303376

DO - 10.1136/gutjnl-2012-303376

M3 - Article

C2 - 23135759

VL - 63

SP - 72

EP - 79

JO - Gut

JF - Gut

SN - 0017-5749

IS - 1

ER -